The Annual ESPID Meeting has become the world's largest meeting in the field of Paediatric Infectious Diseases (PID): it provides the latest information on the number one threat to global child health. There are hundreds of thousands of children worldwide who suffer from infectious diseases. Cases concerning children suffering from tuberculosis, rotavirus, influenza, pneumococci, and zoonotic infections run into the millions.
With these statistics in mind, new discoveries in diagnosis, treatment and prevention are more crucial now than ever. Set in the charming historical city of The Hague, ESPID 2011 provides an ideal opportunity for the best minds in the field from over 100 countries to network as well as share knowledge and expertise. By creating a platform for international scientific collaboration and friendship, ESPID endorses progress and supports those contributing to a better life for children worldwide.
In accordance with the main theme of this meeting, "Frontiers in Paediatric Infectious Diseases," the scientific programme will cover novel research and original contributions by clinicians, researchers and medical professionals on all aspects of PID. Highlights include the latest information on a new Meningococcal Group B Vaccine and groundbreaking information on the impact of vaccination programmes against pneumococci, rotavirus and influenza. Participants will also be presented with the Blue Book, Europe's answer to the American Red Book. The Blue Book aims to be the definitive European guide for the treatment of PID.
Other frontline topics include global health in children, the status of Paediatric AIDS worldwide, the emergence of novel zoonotic infections, the development of antimicrobial resistance in PID, the containment of pertussis, and the control of neglected tropical diseases.
As California taps pandemic stockpile for bird flu, officials keep close eye on spending